Schumer: Senate will vote again on $35 insulin cap after GOP blocked it

Senate Majority Chief Charles Schumer (D-N.Y.) mentioned Monday evening that he’s going to deliver a $35 cap on sufferers’ insulin prices again up for a vote this fall after Republicans blocked it over the weekend.  

“They blocked a $35 value for insulin for non-Medicare individuals,” Schumer mentioned on MSNBC’s “The Rachel Maddow Present.” “We’re going to come back again and make them vote on that once more.” 

The transfer will help put strain on Republicans and spotlight what Democrats view as a successful difficulty forward of November’s midterm elections.  

Democrats hammered Republicans for voting in opposition to the $35 cap over the weekend.  

That vote got here up within the context of overruling the parliamentarian’s resolution that making use of the $35 cap to individuals with non-public medical insurance violated the sophisticated Senate guidelines Democrats have been utilizing to bypass a GOP filibuster.

Seven Republicans nonetheless voted with all 50 Democrats, three wanting the 60 votes wanted, and it’s potential extra Republicans would assist it if it got here up as a standalone measure, not within the context of a Senate guidelines vote.  

“We acquired all 50 Democrats,” Schumer mentioned in a separate interview Monday on NPR. “We did get seven Republicans. We’re going to deliver that again within the fall, as a result of there’s going to be large warmth on Republicans.” 

Schumer didn’t specify whether or not he would deliver the $35 cap up by itself or as half of a bigger, bipartisan insulin measure from Sens. Jeanne Shaheen (D-N.H.) and Susan Collins (R-Maine), which had beforehand confronted difficulties gaining sufficient GOP assist.  

Sen. Chuck Grassley (R-Iowa) steered Monday he would assist a $35 cap if it got here up once more.  

“Vote on the cap was not [about] insulin It was [about] Dems ignoring funds guidelines,” he tweeted. “Expensive colleagues be part of me in supporting the Collins-Shaheen invoice to cap insulin at $35 & enact [pharmacy benefit manager] reforms in bipartisan method.” 

Source link

Related Articles

Back to top button